All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke

被引:16
作者
Braun, Karl F. [1 ,2 ]
Otter, Wolfgang [2 ]
Sandor, Stefanie M. [2 ]
Standl, Eberhard [2 ]
Schnell, Oliver [2 ]
机构
[1] TUM, Klinikum Rechts Isar, Klin & Poliklin Unfallchirurg, Clin Trauma & Orthoped Surg,MRI, D-81675 Munich, Germany
[2] Helmholtz Ctr, Diabet Res Inst, Berlin, Germany
关键词
Diabetes mellitus; Stroke; All-cause in-hospital mortality; Comorbidity; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; RISK-FACTOR; ISCHEMIC-STROKE; HEART-DISEASE; MELLITUS; PREVALENCE; RECURRENCE; IMPACT; DEATH;
D O I
10.1016/j.diabres.2012.04.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The aim of this study was to compare diabetic and non-diabetic patients with stroke with regard to their all-cause in-hospital mortality and possible differences regarding their comorbidities. Methods: All patients of the Munich Stroke Registry (2003-2004, n = 537) were assessed. Hospital mortality in diabetic (n = 160, 29.8%) and non-diabetic (n = 377, 70.2%) patients was compared. Pre-existing comorbidities such as hypertension, coronary artery disease (CAD), peripheral arterial disease (PAD), albuminuria and impaired renal function (IRF) were noted. Results: Regarding all-cause in-hospital mortality, no significant differences were found between diabetic and non-diabetic patients. Overall 71 patients (13.2%) died of whom 27 (16.9%) where diabetic and 44 (11.7%) non-diabetic patients (n.s.). Hypertension, CAD, PAD, albuminuria and IRF were more frequent in diabetic patients (p < 0.05). Conclusion: Despite multiple comorbidities and risk factors no significant difference in all-cause in-hospital mortality was seen in diabetic patients as compared to non-diabetic patients. Improved treatment strategies and early intervention may compensate for their poorer prognosis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 33 条
  • [1] The role of c-reactive protein in cardiovascular disease risk
    Albert M.A.
    [J]. Current Cardiology Reports, 2000, 2 (4) : 274 - 279
  • [2] ASPLUND K, 1980, ACTA MED SCAND, V207, P417
  • [3] Borch-Johnsen K, 1999, LANCET, V354, P617
  • [4] Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
    Borch-Johnsen, K
    Neil, A
    Balkau, B
    Larsen, S
    Nissinen, A
    Pekkanen, J
    Tuomilehto, J
    Jousilahti, P
    Lindstrom, J
    Pyörälä, M
    Pyörälä, K
    Eschwege, E
    Gallus, G
    Garancini, MP
    Bouter, LM
    Dekker, JM
    Heine, RJ
    Nijpels, HG
    Stehouwer, CDA
    Feskens, EJM
    Kromhout, D
    Peltonen, M
    Pajak, A
    Eriksson, J
    Qiao, Q
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) : 397 - 405
  • [5] Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
    Danaei, Goodarz
    Lawes, Carlene M. M.
    Hoorn, Stephen Vander
    Murray, Christopher J. L.
    Ezzati, Majid
    [J]. LANCET, 2006, 368 (9548) : 1651 - 1659
  • [6] Diabetes and stroke
    Das R.R.
    Seshadri S.
    [J]. Current Cardiovascular Risk Reports, 2009, 3 (1) : 35 - 41
  • [7] Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke
    Di Napoli, M
    Papa, F
    Bocola, V
    [J]. STROKE, 2001, 32 (01) : 133 - 138
  • [8] Heckmann JG, 2009, DIABETOLOGE, V5, P605, DOI 10.1007/s11428-009-0443-8
  • [9] STROKE RECURRENCE WITHIN 2 YEARS AFTER ISCHEMIC INFARCTION
    HIER, DB
    FOULKES, MA
    SWIONTONIOWSKI, M
    SACCO, RL
    GORELICK, PB
    MOHR, JP
    PRICE, TR
    WOLF, PA
    [J]. STROKE, 1991, 22 (02) : 155 - 161
  • [10] High-Sensitivity C-Reactive Protein is a Strong Risk Factor for Death after Acute Ischemic Stroke among Chinese
    Huang, Yue
    Jing, Jing
    Zhao, Xing-Quan
    Wang, Chun-Xue
    Wang, Yi-Long
    Liu, Gai-Fen
    Wang, Chun-Juan
    Liu, Li-Ping
    Yang, Xiao-Meng
    Jiao, Yan
    Jiao, Yun
    Wang, Li-Shi
    Wang, Yong-Jun
    Gu, Wei-Kuan
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (03) : 261 - 266